ETFChannel.com
LLY Description — Lilly (Eli) & Co

Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s human pharmaceutical products include: diabetes and other endocrinology products, immunology products, neuroscience products, oncology products, and other products. Co.'s diabetes and other endocrinology products include: Baqsimi® and Basaglar®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta® and Emgality®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux® and Verzenio®. Co.'s other products include: Cialis®.

Company Name: 
Lilly (Eli) & Co
Website: 
www.lilly.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding LLY: 
105
Total Market Value Held by ETFs: 
$10,965,384,821.08
Total Market Capitalization: 
$135,215,000,000
% of Market Cap. Held by ETFs: 
8.11%
 ETF   LLY Weight   LLY Amount 
 VTI   0.36%   $3,421,937,494         
 VOO   0.42%   $2,371,678,356         
 IVV   0.42%   $927,343,274         
 VTV   0.87%   $796,178,516         
 VYM   1.10%   $437,049,556         
 USMV   1.00%   $403,236,686         
 IWF   0.72%   $382,142,016         
 QUAL   1.81%   $329,809,138         
 VHT   2.67%   $312,990,024         
 IVW   0.43%   $113,642,722         
List of all 105 ETFs holding LLY »
Quotes delayed 20 minutes

Strong Buy (3.56 out of 4)
68th percentile
(ranked higher than approx. 68% of all stocks covered)

Analysts Forecast:
LLY Price Target

Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding LLY | Lilly (Eli) & Co | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2020, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.